This suggests BPC-157 could potentially improve benzodiazepine efficacy during chronic treatment and ease withdrawal, but no human studies have tested this
Smith E, Meyerrose TE, Kohler T, Namdar-Attar M, Bab N, Lahat O, et al
The simplest way to think about it: Wegovy and Zepbound work by targeting specific receptors in your bodyWegovy focuses on GLP-1, while Zepbound activates both GLP-1 and GIP receptors
A large protein, BPC was claimed in a 1994 US patent (#5,288,708) to have been isolated from both human and animal gastric juice and to exert a wide-range of protective effects in organ injury models
Why TB-500 Alone Often Falls Short TB-500 improves coordination, but coordination without fuel still fails